These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 33320604)

  • 21. In Vitro Cytotoxicity and In Vivo Antitumor Activity of Lipid Nanocapsules Loaded with Novel Pyridine Derivatives.
    Abu Lila AS; Amran M; Tantawy MA; Moglad EH; Gad S; Alotaibi HF; Obaidullah AJ; Khafagy ES
    Pharmaceutics; 2023 Jun; 15(6):. PubMed ID: 37376202
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Polyethyleneimine- -Tocopherol Hydrogen Succinate/Hyaluronic Acid-Quercetin (PEI-TOS/HA-QU) Core-Shell Micelles Delivering Paclitaxel for Combinatorial Treatment of MDR Breast Cancer.
    Qian J; Liu S; Yang T; Xiao Y; Sun J; Zhao J; Zhang Z; Xie Y
    J Biomed Nanotechnol; 2021 Mar; 17(3):382-398. PubMed ID: 33875073
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Enhanced drug-loading and therapeutic efficacy of hydrotropic oligomer-conjugated glycol chitosan nanoparticles for tumor-targeted paclitaxel delivery.
    Koo H; Min KH; Lee SC; Park JH; Park K; Jeong SY; Choi K; Kwon IC; Kim K
    J Control Release; 2013 Dec; 172(3):823-31. PubMed ID: 24035978
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Paclitaxel loaded folic acid targeted nanoparticles of mixed lipid-shell and polymer-core: in vitro and in vivo evaluation.
    Zhao P; Wang H; Yu M; Liao Z; Wang X; Zhang F; Ji W; Wu B; Han J; Zhang H; Wang H; Chang J; Niu R
    Eur J Pharm Biopharm; 2012 Jun; 81(2):248-56. PubMed ID: 22446630
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Paclitaxel-loaded Nanolipidic Carriers with Improved Oral Bioavailability and Anticancer Activity against Human Liver Carcinoma.
    Harshita ; Barkat MA; Rizwanullah M; Beg S; Pottoo FH; Siddiqui S; Ahmad FJ
    AAPS PharmSciTech; 2019 Jan; 20(2):87. PubMed ID: 30675689
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Hyaluronic acid decorated pluronic P85 solid lipid nanoparticles as a potential carrier to overcome multidrug resistance in cervical and breast cancer.
    Wang F; Li L; Liu B; Chen Z; Li C
    Biomed Pharmacother; 2017 Feb; 86():595-604. PubMed ID: 28027535
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Enhanced anti-tumor efficacy of paclitaxel with PEGylated lipidic nanocapsules in presence of curcumin and poloxamer: In vitro and in vivo studies.
    Anwar M; Akhter S; Mallick N; Mohapatra S; Zafar S; Rizvi MMA; Ali A; Ahmad FJ
    Pharmacol Res; 2016 Nov; 113(Pt A):146-165. PubMed ID: 27546165
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Novel free-paclitaxel-loaded redox-responsive nanoparticles based on a disulfide-linked poly(ethylene glycol)-drug conjugate for intracellular drug delivery: synthesis, characterization, and antitumor activity in vitro and in vivo.
    Chuan X; Song Q; Lin J; Chen X; Zhang H; Dai W; He B; Wang X; Zhang Q
    Mol Pharm; 2014 Oct; 11(10):3656-70. PubMed ID: 25208098
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Immunotherapeutic vitamin E nanoemulsion synergies the antiproliferative activity of paclitaxel in breast cancer cells via modulating Th1 and Th2 immune response.
    Pawar VK; Panchal SB; Singh Y; Meher JG; Sharma K; Singh P; Bora HK; Singh A; Datta D; Chourasia MK
    J Control Release; 2014 Dec; 196():295-306. PubMed ID: 25459427
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Codelivery of Paclitaxel and Everolimus at the Optimal Synergistic Ratio: A Promising Solution for the Treatment of Breast Cancer.
    Houdaihed L; Evans JC; Allen C
    Mol Pharm; 2018 Sep; 15(9):3672-3681. PubMed ID: 29863881
    [TBL] [Abstract][Full Text] [Related]  

  • 31. An optimized two-vial formulation lipid nanoemulsion of paclitaxel for targeted delivery to tumor.
    Chen L; Chen B; Deng L; Gao B; Zhang Y; Wu C; Yu N; Zhou Q; Yao J; Chen J
    Int J Pharm; 2017 Dec; 534(1-2):308-315. PubMed ID: 28986321
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Free paclitaxel-loaded E-selectin binding peptide modified micelle self-assembled from hyaluronic acid-paclitaxel conjugate inhibit breast cancer metastasis in a murine model.
    Han X; Dong X; Li J; Wang M; Luo L; Li Z; Lu X; He R; Xu R; Gong M
    Int J Pharm; 2017 Aug; 528(1-2):33-46. PubMed ID: 28576551
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Experimental design of a liposomal lipid system: A potential strategy for paclitaxel-based breast cancer treatment.
    Barbosa MV; Monteiro LO; Carneiro G; Malagutti AR; Vilela JM; Andrade MS; Oliveira MC; Carvalho-Junior AD; Leite EA
    Colloids Surf B Biointerfaces; 2015 Dec; 136():553-61. PubMed ID: 26454545
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cytotoxicity Enhancement of Paclitaxel by Loading on Stearate-g-dextran Micelles on Breast Cancer Cell Line MCF-7.
    Ghaffari F; Bahmanzadeh M; Nili-Ahmadabadi A; Firozian F
    Asian Pac J Cancer Prev; 2018 Sep; 19(9):2651-2655. PubMed ID: 30256563
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Improving anti-tumor activity with polymeric micelles entrapping paclitaxel in pulmonary carcinoma.
    Gong C; Xie Y; Wu Q; Wang Y; Deng S; Xiong D; Liu L; Xiang M; Qian Z; Wei Y
    Nanoscale; 2012 Sep; 4(19):6004-17. PubMed ID: 22910790
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Paclitaxel and curcumin coadministration in novel cationic PEGylated niosomal formulations exhibit enhanced synergistic antitumor efficacy.
    Alemi A; Zavar Reza J; Haghiralsadat F; Zarei Jaliani H; Haghi Karamallah M; Hosseini SA; Haghi Karamallah S
    J Nanobiotechnology; 2018 Mar; 16(1):28. PubMed ID: 29571289
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Anti-cancer, pharmacokinetic and biodistribution studies of cremophor el free alternative paclitaxel formulation.
    Jain SK; Utreja P; Tiwary AK; Mahajan M; Kumar N; Roy P
    Curr Drug Saf; 2014; 9(2):145-55. PubMed ID: 24369111
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Simultaneous controlled release of 5-FU, DOX and PTX from chitosan/PLA/5-FU/g-C3N4-DOX/g-C3N4-PTX triaxial nanofibers for breast cancer treatment in vitro.
    Habibi Jouybari M; Hosseini S; Mahboobnia K; Boloursaz LA; Moradi M; Irani M
    Colloids Surf B Biointerfaces; 2019 Jul; 179():495-504. PubMed ID: 31005745
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Paclitaxel-loaded PEGylated nanocapsules of perfluorooctyl bromide as theranostic agents.
    Boissenot T; Fattal E; Bordat A; Houvenagel S; Valette J; Chacun H; Gueutin C; Tsapis N
    Eur J Pharm Biopharm; 2016 Nov; 108():136-144. PubMed ID: 27594209
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Targeted Nanostructured Lipid Carriers for Delivery of Paclitaxel to Cancer Cells: Preparation, Characterization, and Cell Toxicity.
    Rezazadeh M; Emami J; Hassanzadeh F; Sadeghi H; Rostami M; Mohammadkhani H
    Curr Drug Deliv; 2017; 14(8):1189-1200. PubMed ID: 28472908
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.